Alterity Therapeutics Limited
ATHE
$5.07
-$0.09-1.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.13% | -1.26% | -60.01% | -47.91% | -35.16% |
| Total Depreciation and Amortization | -6.40% | 3.78% | 15.29% | 27.50% | 40.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.25% | 172.39% | 449.29% | 576.83% | 941.18% |
| Change in Net Operating Assets | -111.73% | -52.55% | 176.07% | 184.29% | 187.67% |
| Cash from Operations | 9.57% | -2.07% | -11.21% | 16.97% | 38.65% |
| Capital Expenditure | -- | 100.00% | 100.00% | 62.75% | 22.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -24,151.55% | -- | -- | -- |
| Cash from Investing | -125,021.05% | -16,350.35% | 100.00% | 92.34% | 84.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,121.15% | -54.83% | 72.64% | 76.73% | 82.67% |
| Issuance of Common Stock | 319.64% | 342.23% | 489.48% | 931.46% | 3,104.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -202.18% | -182.54% | -123.79% | -265.35% | -593.35% |
| Cash from Financing | 314.99% | 346.98% | 631.24% | 1,272.79% | 7,116.55% |
| Foreign Exchange rate Adjustments | -174.04% | -95.71% | -53.26% | -65.62% | -72.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 725.04% | 169.74% | 41.00% | 66.10% | 84.03% |